Baxter inks partnership deal with International Society of Nephrology

Baxter (NYSE:BAX) said today it inked a partnership deal with the International Society of Nephrology looking to advance awareness and therapy for patients with chronic kidney disease, primarily in low and middle-income countries where the disease is growing the fastest. In the collaborative partnership , Deerfield, Ill.-based Baxter and the ISN will look to support further therapy research and education about chronic kidney disease, while also looking to develop better care models at lower costs. “ISN and Baxter’s collaboration aims to address the urgent and growing challenge kidney disease is causing healthcare systems in providing quality care to patients globally. Our organization is dedicated to connecting communities to collaborate on supporting greater access to care models that focus on how to improve prevention, diagnosis and treatment of kidney disease,” Dr. David Harris of Australia’s University of Sydney said in a prepared statement. “It is Baxter’s goal to make renal care available to people in need, while driving better outcomes through new standards. Our partnership with ISN moves us closer to this goal by combining Baxter’s clinical and innovation expertise with ISN’s educational and research expertise in a truly transformative approach to increasing access to care worldwide,” Baxter renal care GM Laura Angelini said in a press release. In March, Baxter said it that it closed the $153 million acquisiti...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Baxter Source Type: news

Related Links:

Publication date: Available online 10 December 2018Source: American Journal of Kidney DiseasesAuthor(s): Christopher T. Chan, Eric Wallace, Thomas A. Golper, Mitchell H. Rosner, Rebecca Kurnik Seshasai, Joel D. Glickman, Martin Schreiber, Patrick Gee, Michael V. RoccoHome dialysis therapy, including home hemodialysis and peritoneal dialysis, is underused as a modality for the treatment of chronic kidney failure. The National Kidney Foundation–Kidney Disease Outcomes Quality Initiative sponsored a home dialysis conference in late 2017 that was designed to identify the barriers to starting and maintaining patients on h...
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
Publication date: Available online 10 December 2018Source: American Journal of Kidney DiseasesAuthor(s): Richard L. Amdur, Harold I. Feldman, Elizabeth A. Dominic, Amanda H. Anderson, Srinivasan Beddhu, Mahboob Rahman, Myles Wolf, Muredach Reilly, Akinlolu Ojo, Raymond R. Townsend, Alan S. Go, Jiang He, Dawei Xie, Sally Thompson, Matthew Budoff, Scott Kasner, Paul L. Kimmel, John W. Kusek, Dominic S. Raj, Jeffrey FinkRationale &ObjectiveTraditional risk estimates for atherosclerotic vascular disease (ASVD) and death may not perform optimally in the setting of chronic kidney disease (CKD). We sought to determine whether...
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
Condition:   CKD Intervention:   Drug: LCZ 696 Sponsor:   The Second Affiliated Hospital of Harbin Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Chronic Kidney Diseases Intervention:   Sponsors:   Ass. Prof. Dr. Manfred Hecking, MD;   Karolinska Institutet Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
We examined the prospective association between hepatitis B surface antigen (HBsAg) serolog...
Source: BMC Nephrology - Category: Urology & Nephrology Authors: Tags: Research article Source Type: research
Author Correction: Lipid management in patients with chronic kidney disease, Published online: 11 December 2018; doi:10.1038/s41581-018-0099-yAuthor Correction: Lipid management in patients with chronic kidney disease
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Source Type: research
MONDAY, Dec. 10, 2018 -- Women may have a lower risk for chronic kidney disease (CKD) progression and death compared with men, according to a study published online Dec. 3 in the Journal of the American Society of Nephrology. Ana C. Ricardo, M.D.,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
MONDAY, Dec. 10, 2018 -- Chronic kidney disease is more likely to progress to kidney failure and death in men than in women, a new study reveals. " We found that women had 17 percent lower risk of experiencing [kidney failure] and the risk of death...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Discussion Intrauterine growth retardation or fetal growth retardation is due to a pathological process that causes decelerated fetal growth velocity. Small-for-gestational age (SGA) is an infant with growth parameters below the normal range for gestational age. More commonly, SGA is defined as a birth weight
Source: PediatricEducation.org - Category: Pediatrics Authors: Tags: Uncategorized Source Type: news
AbstractPrimary hyperoxaluria (PH) is caused by genetic mutations resulting in oxalate overproduction leading to nephrolithiasis, nephrocalcinosis, extrarenal manifestations, chronic kidney disease, and end-stage renal disease. Advances in genetic testing techniques have improved our ability to efficiently and effectively obtain a definitive diagnosis of PH as well as easily screen at-risk family members. Similarly, advances in technologies related to intervening at the genetic and molecular level promise to change the way we treat patients with PH. In this review, we provide an update regarding the identification of under...
Source: Urolithiasis - Category: Urology & Nephrology Source Type: research
More News: Australia Health | Chronic Kidney Disease | Education | Mergers and Aquisitions | Partnerships | Universities & Medical Training | Urology & Nephrology